We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
+7.45%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$12.5B
AUM Growth
-$3.15B
(-20%)
Cap. Flow
-$379M
Cap. Flow
% of AUM
-3.02%
Top 10 Holdings %
Top 10 Hldgs %
24.56%
Holding
444
New
28
Increased
114
Reduced
119
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BILL Holdings
BILL
|
+$65.8M |
| 2 |
Pinterest
PINS
|
+$54M |
| 3 |
Shopify
SHOP
|
+$51.3M |
| 4 |
Trip.com Group
TCOM
|
+$50.7M |
| 5 |
Visa
V
|
+$49.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ON Semiconductor
ON
|
+$98.2M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$83.6M |
| 3 |
Microsoft
MSFT
|
+$73.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$58.8M |
| 5 |
Synopsys
SNPS
|
+$57.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.52% |
| 2 | Healthcare | 24.95% |
| 3 | Financials | 23.79% |
| 4 | Communication Services | 4.6% |
| 5 | Consumer Discretionary | 4.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Privia Health
PRVA
$2.64B
| $585K | ﹤0.01% |
25,765
+6,635
| +35% | +$185K |
|
252
Albemarle
ALB
$13.4B
| $575K | ﹤0.01% |
2,650
-20,238
| -88% | -$5.39M |
|
253
iRhythm Holdings
IRTC
$3.66B
| $539K | ﹤0.01% |
5,750
| – | – |
|
254
Esquire Financial Holdings
ESQ
$1.46B
| $538K | ﹤0.01% |
12,436
-4,808
| -28% | -$204K |
|
255
NXP Semiconductors
NXPI
$57.1B
| $521K | ﹤0.01% |
3,300
-7,911
| -71% | -$1.25M |
|
256
Arrowhead Research
ARWR
$10.4B
| $509K | ﹤0.01% |
12,547
| – | – |
|
|
MDRX
257
DELISTED
Veradigm Inc. Common Stock
MDRX
| $491K | ﹤0.01% |
27,855
| – | – |
|
258
Pacira BioSciences
PCRX
$954M
| $486K | ﹤0.01% |
12,595
| – | – |
|
259
JD.com
JD
$36.7B
| $483K | ﹤0.01% |
8,606
-2,942
| -25% | -$148K |
|
260
Huazhu Hotels Group
HTHT
$13.3B
| $479K | ﹤0.01% |
11,296
-6,201
| -35% | -$224K |
|
261
Progyny
PGNY
$2.14B
| $453K | ﹤0.01% |
14,558
| – | – |
|
262
Repligen
RGEN
$9.83B
| $423K | ﹤0.01% |
2,500
| – | – |
|
263
Surgery Partners
SGRY
$1.79B
| $405K | ﹤0.01% |
14,552
-538,466
| -97% | -$14.3M |
|
264
Trimble
TRMB
$13.7B
| $404K | ﹤0.01% |
8,000
-13,522
| -63% | -$753K |
|
|
LTHM
265
DELISTED
Livent Corporation
LTHM
| $367K | ﹤0.01% |
18,450
-181,061
| -91% | -$4.95M |
|
|
APLS
266
DELISTED
Apellis Pharmaceuticals
APLS
| $357K | ﹤0.01% |
6,900
| – | – |
|
267
Azenta
AZTA
$1.45B
| $323K | ﹤0.01% |
5,540
| – | – |
|
268
Castle Biosciences
CSTL
$1.06B
| $315K | ﹤0.01% |
13,398
-35,587
| -73% | -$825K |
|
269
Bruker
BRKR
$8.44B
| $306K | ﹤0.01% |
+4,475
| New | +$284K |
|
270
Health Catalyst
HCAT
$132M
| $283K | ﹤0.01% |
26,640
| – | – |
|
271
PayPal
PYPL
$45.8B
| $279K | ﹤0.01% |
3,917
-83,024
| -95% | -$6.64M |
|
272
NetEase
NTES
$76.3B
| $274K | ﹤0.01% |
3,768
+478
| +15% | +$32.5K |
|
273
KE Holdings
BEKE
$17.8B
| $261K | ﹤0.01% |
18,661
-4,349
| -19% | -$60.4K |
|
|
EXAS
274
DELISTED
Exact Sciences
EXAS
| $215K | ﹤0.01% |
+4,335
| New | +$177K |
|
275
Stereotaxis
STXS
$132M
| $159K | ﹤0.01% |
76,687
| – | – |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q4 2022 Portfolio in Review
As of Q4 2022, Polar Capital Holdings held 444 positions worth $12.5B, down 20% from $15.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Polar Capital Holdings withdrew a net $379M in Q4 2022, closing 135 positions and reducing 119 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $83.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Polar Capital Holdings opened a new position in Pinterest worth $55M.
- Polar Capital Holdings's largest Q4 2022 buy was Pinterest: 2,264,255 shares worth $55M.
- Polar Capital Holdings added most to BILL Holdings in Q4 2022, an estimated $65.8M increase.
- Polar Capital Holdings's biggest Q4 2022 reduction was ON Semiconductor, cutting an estimated $98.2M.
- Polar Capital Holdings fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, selling an estimated $83.6M.
- Polar Capital Holdings's ten largest holdings make up 25% of its $12.5B portfolio in Q4 2022.
- Polar Capital Holdings opened 28 new positions and closed 135 in Q4 2022.
- Polar Capital Holdings's portfolio value fell 20% quarter-over-quarter to $12.5B.
Based on Polar Capital Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.